UBX

Unity Biotechnology

Delisted

UBX was delisted on the 8th of July, 2025.

74 hedge funds and large institutions have $127M invested in Unity Biotechnology in 2020 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 23 increasing their positions, 23 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
74
Holders Change
-5
Holders Change %
-6.33%
% of All Funds
1.63%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.04%
New
10
Increased
23
Reduced
23
Closed
14
Calls
$122K
Puts
$1K
Net Calls
+$121K
Net Calls Change
+$123K
Name Holding Trade Value Shares
Change
Shares
Change %
Two Sigma Investments
76
Two Sigma Investments
New York
-$251K -3,477 Closed
D.E. Shaw & Co
77
D.E. Shaw & Co
New York
-$250K -3,471 Closed
OGC
78
One68 Global Capital
New York
-$149K -2,072 Closed
CS
79
Credit Suisse
Switzerland
-$129K -1,799 Closed
Walleye Capital
80
Walleye Capital
New York
-$123K -1,704 Closed
ProShare Advisors
81
ProShare Advisors
Maryland
-$100K -1,382 Closed
BFM
82
Boothbay Fund Management
New York
-$99K -1,375 Closed
Walleye Trading
83
Walleye Trading
New York
-$75K -1,034 Closed
PPA
84
Parametric Portfolio Associates
Washington
-$73K -1,008 Closed
CSS
85
Cubist Systematic Strategies
Connecticut
-$54K -749 Closed
Bank of Montreal
86
Bank of Montreal
Ontario, Canada
-$26K -359 Closed
PHK
87
Point72 Hong Kong
Hong Kong
-$26K -357 Closed